Vaccines market research reports by China Research and Intelligence Co., Ltd.

Investigation Report on China's Shingles Vaccine Market 2022-2031

Jul 25, 2022  |  Published by: China Research and Intelligence Co., Ltd.  |  USD 3,200

Investigation Report on China's Shingles Vaccine Market 2022-2031 The trade name of shingles vaccine (recombinant zoster vaccine) is SHINGRIX, which was developed by GlaxoSmithKline. Its product was firstly approved in China in 2020. Shingles vaccine is suitable for adults aged 50 years and over to ... Read More